Clinical Trial

RTMS for CHR Based on Personalized Targets Using Magnetoencephalography

Recruiting
View on ClinicalTrials.gov →
Summary
This study is an before-after study in the same subject, which enrolled 26 individuals with high-risk psychiatric syndrome (CHR). The target of subjects intervention relies on the results of magnetoencephalography localization. The medication and dosage remain unchanged during the intervention period or not yet taking antipsychotic medication. The investigators assume that the intervention targets for each CHR subject are individualized.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-01-26; most recent amendment 2025-02-09.
Status change: Not Yet Recruiting → Recruiting 2025-02-09
Trial Details
NCT Number NCT06802952
Lead Sponsor Shanghai Mental Health Center
Conditions Clinical High-risk Syndrome of Psychosis
Enrollment 26 participants
Start Date 2025-02-07
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-11